Patent · US Active

Disubstituted heteroaryl-fused pyridines

US8742106B2 · kind B2 · utility

3Cited by

2References

16Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Sangamesh Badiger · Bengaluru, IN
Dirk Behnke · Weil am Rhein, DE
Claudia Betschart · Basel, CH
Vinod Chaudhari · Savanuru, IN
Murali Chebrolu · Darsi, IN
Simona Cotesta · Basel, CH
Samuel Hintermann · Basel, CH
Arndt Meyer · Basel, CH
Chetan Pandit · Edmonton, CA

Key dates

Filing date	Dec 20, 2010
Grant date	Jun 3, 2014
Priority date	—
Expiry date	Dec 20, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compound of the formula (I′) in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.